Dopaminagonists and fibrotic valvular heart disease: further considerations.
Rascol
Olivier
O
Pathak
Atul
A
Bagheri
Haleh
H
Montastruc
J-L
JL
D018491:Dopamine Agonists / Q000009:adverse effects*; D005355:Fibrosis / Q000139:chemically induced*; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D010479:Pergolide / Q000009:adverse effects*
D018491:Dopamine Agonists; D010479:Pergolide